- Chittajallu RS, Dorrian CA, Ardill JES, McColl KEL. Effect of Helicobacter pylori on serum pepsinogen I and plasma gastrin in duodenal ulcer patients. Scand J Gastroenterol 1992;27:20-4.
- Gisbert JP, Boixeda D, Vila T, Rafael L, Redond C, Argila CM. Basal and stimulated gastrin levels and gastric acid output five month after therapy for Helicobacter pylori eradication in duodenal ulcer patients. J. Clin Gastroenterol 1996;22:90-5.
- Perez-Paramo M, Albillos A, Calleja JL, Salas C, Marin MDC, Marcos ML, et al. Changes in gastrin and serum pepsinogens in monitoring of Helicobacter pylori response to therapy. Dig Dis Sci 1997;42:1734-40.
- Gisbert JP, Bioxeda D, Al-Mostafa A, Vila T, Rafael L, Baleriola IB, et al. Basal and stimulated gastrin and pepsinogen levels after eradication of Helicobacter Pylori: a 1-year follow-up study. Eur J Gastroenterol Hepatol 1999;11:189-200.
- Al-Assi MT, Miki K, Walsh JH, Graham DP, Asaka M, Graham DY, et al. Noninvasive evaluation of Helicobacter pylori therapy: role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodies. Am J Gastroenterol 1999;94:2367-72.
- Iijima K, Ohara S, Sekine H, Koike T, Kato K, Asaki S, et al. Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication. Gut 2000;46:20-6.
- Matsushima Y, Kinoshita Y, Nakata H, Inomoto-Naribayashi Y, Asahara M, Kawanami C, et al. Gastrin receptor gene expression in several human carcinomas. Jpn J Cancer Res 1994;85:819-24.
- Watson SA, Michaeli D, Grimes S, Morris TM, Robinson G, Varro A, et al. Gastrimmune raises antibodies that neutralize amidated and glycine-extended gastrin-17 and inhibit the growth on colon cancer. Cancer Res 1996;56:880-5.
- Thorburn CM, Friedman GD, Dickinson CJ, Vogelman JH, Orentreich N, Parsonnet J. Gastrin and colorectal cancer: a prospective study. Gastroenterology 1998;115:275-80.
- Szabo I, Rumi G, Bodis B, Nemeth P, Mozsik G. Gastrin and pentagastrin enhance the tumour proliferation of human stable cultured gastric adenocarcinoma cells. J. Physiol (Paris) 2000;94:71-4.
- Iwase K, Evers BM, Hellmich MR, Guo YS, Higashide S, Kim HJ, et al. Regulation of growth of human gastric cancer by gastrin and glycine-extended progastrin. Gastroenterology 1997;113:782-90.
- Isaacson PG. Gastric MALT Iymphoma: from concept to cure. Ann Oncol 1999;10:637-45.
- Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993;342:575-7.
- Thiede C, Wundisch T, Neubauer B, Alpen B, Morgner A, Ritter M. Eradication of Helicobacter pylori and stability of remissions in low-grade gastric B-cell lymphomas of the mucosa-associated lymphoid tissue: results of an ongoing multicenter trial. Recent results in cancer res 2000;156:125-33.
- Konturek PC, Konturek SJ, Starzyska T, Marliez K, Bielanski W, Pierzchalski P, et al. Helicobacter pylori-gastrin link in MALT lymphoma. Aliment Pharmacol The 2000;14:1311-8.
- Maekawa T, Kinoshita Y, Fukui H, Matsumoto S, Hirota S, Chihara K, et al. Reciprocal changes in progression of gastric mucosa-associated lymphoid tissue lymphoma and pancreatic somatostatinoma. Am J Med 1998; 105:539-41.
- Tham TCK, Chen L, Dennison N, Johnston CF, Collins JSA, Ardill JES, et al. Effect of Helicobacter pylori eradication on antral somatostatin cell density in humans. Eur J Gastroenterol Hepatol 1998;10:289-91.
Scandinavian Journal of Gastroenterology
Volume 37, 2002 - Issue 3